Selectivity comes from coordination between immobilized nickel ions and histidine residues in the engineered polyhistidine tag. Proteins lacking the tag do not form the same binding interaction, so they are removed during washing while the tagged molecule remains associated with the column. This chemical recognition enables target enrichment from a complex cell lysate.
Imidazole releases the bound protein by competing with histidine residues for available nickel-binding sites. Adding it after washing changes the competition at the column, allowing the tagged target to leave the immobilized nickel while proteins that already passed through remain separated. The result is recovery of the engineered protein rather than continued retention on the column.
Washing removes proteins that have not formed the intended nickel-histidine interaction. Because the target remains associated through its polyhistidine tag, this stage improves separation before imidazole is introduced. The distinction is especially important when starting with complex lysates, where many cellular proteins are present and could otherwise accompany the recombinant molecule into later experiments.
The workflow uses a cell lysate as the starting material, followed by passage through the column, washing to remove non-target proteins, and imidazole addition to elute the retained tagged protein. Keeping these stages distinct separates binding from recovery and provides a practical route to obtaining purified material for immunology, infection, or structural studies.
Purified recombinant antigens can support antibody production and immune assays, where unwanted proteins from the original lysate could complicate interpretation. A Nickel Affinity Column provides a selective route to prepare these molecules before downstream use. The same purification approach can also supply other recombinant proteins needed for investigating immune recognition or related biological responses.
In infection research, purified recombinant enzymes and other proteins can provide defined material for examining pathogen biology. The method can also prepare proteins for structural studies, helping researchers work with a selected molecule rather than an unfractionated lysate. Its selective binding and straightforward workflow support reproducible preparation across experiments involving infectious-disease mechanisms.